BioDelivery Sciences - Stock Price History | BDSI

Historical daily share price chart and data for BioDelivery Sciences since 2021 adjusted for splits. The latest closing stock price for BioDelivery Sciences as of October 22, 2021 is 4.14.
  • The all-time high BioDelivery Sciences stock closing price was 18.15 on September 12, 2014.
  • The BioDelivery Sciences 52-week high stock price is 4.99, which is 20.5% above the current share price.
  • The BioDelivery Sciences 52-week low stock price is 3.04, which is 26.6% below the current share price.
  • The average BioDelivery Sciences stock price for the last 52 weeks is 3.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BioDelivery Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.3744 6.1700 6.1700 3.0600 4.2000 -33.54%
2019 4.8467 3.6500 7.0600 3.6500 6.3200 70.81%
2018 2.7590 2.8500 4.0000 1.7000 3.7000 25.42%
2017 2.4638 1.7500 3.5000 1.6000 2.9500 68.57%
2016 2.7507 4.5300 4.8900 1.6000 1.7500 -63.47%
2015 8.7698 12.2400 15.3200 4.7500 4.7900 -60.15%
2014 11.8687 5.7800 18.1500 5.7500 12.0200 104.07%
2013 4.7251 4.5100 5.9800 3.7600 5.8900 36.66%
2012 3.9370 0.8200 6.7800 0.8169 4.3100 435.34%
2011 2.8235 3.5500 3.9900 0.7801 0.8051 -77.32%
2010 3.1219 4.0000 4.3100 2.1300 3.5500 -9.67%
2009 4.4780 2.9000 6.9400 2.7800 3.9300 35.52%
2008 2.5244 2.9300 3.9900 1.7000 2.9000 -1.02%
2007 4.0399 3.0900 6.3000 2.3400 2.9300 -8.07%
2006 2.4304 2.4300 3.4100 1.9000 3.1871 28.51%
2005 2.7425 3.3100 3.7900 1.7000 2.4800 -29.55%
2004 3.2358 2.9700 4.1500 1.5200 3.5200 29.89%
2003 2.9829 2.0500 4.9000 1.6000 2.7100 42.63%
2002 2.3599 3.3000 3.4500 1.3000 1.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.408B $0.156B
BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any process, substance, or combination thereof, that delivers drugs into the body.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76